Data sharing significantly impacts drug development by streamlining the process of identifying potential drug candidates and assessing their effectiveness. When pharmaceutical companies and research institutions share data, it reduces the time and cost associated with clinical trials. This collaborative approach can also lead to the discovery of new drug targets and combination therapies, ultimately bringing effective treatments to market more quickly.
